Preclinical data show that adding a BRAF- to a MEK-inhibitor inhibits ERK-phosphorylation and cell growth and induces apoptosis in NRAS mutant melanoma models by inducing endoplasmic reticulum stress [6]. The gene discussed is BRAF; the disease is melanoma.